Cryosite logo
CTE
Pharmaceuticals, Biotechnology & Life Sciences

Cryosite

Short interest
0.00%
as of 23 May 2025
Reported shorts
634
Shares on issue
48.810M

Cryosite (CTE) financials

Results, ratios and statements

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency

Revenue
$16.7Mvs $14.1M (FY25)
Yahoo Finance, as at 14 Oct 2026
NPAT
$2.2Mvs $1.9M (FY25)
Yahoo Finance, as at 14 Oct 2026
EPS (diluted)
$0.043 (source: Derived: trailing 12 months at year end)vs $0.038 (FY25)
Derived: trailing 12 months at year end, as at 14 Oct 2026
Rev YoY
+18.3%FY
EPS YoY
+14.8%TTM
  • Derived: trailing 12 months at year end

Summary of Appendix 4E and 2026 Annual Report, 18 Aug 2026

Cryosite Limited reported revenue of $16.7 million for FY26, up 18% from the prior year, and net profit after tax of $2.2 million, up 19%. The Board resolved not to declare a dividend for FY26, as cash was used to acquire a new warehouse facility and expand capacity. The company noted record earnings and operating volumes, with growth across all temperature-controlled segments.

Automated summary of the filing; the filing itself is the record.

Key ratios

Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 14 Oct 2026

Gross margin
62.4%
Operating margin
18.9%
Net margin
13.4%
FCF margin
−48.2%
ROE
61.7%
ROA
9.8%
FCF conversion
−3.60×
Net debt (excl. leases)
$3.4M
Net debt / EBITDA
0.8×
Current ratio
1.3×
Interest cover
14.6×
Cash dividends paid / net profit
n/a
Market cap
$58.8M
P/E
27.8×
P/B
12.1×

Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 14 Oct 2026.

Financial statements

Figures in AUD, the reporting currency; Yahoo Finance unless marked

CTE income, newest period first, figures in AUD
Line itemFY26FY25FY24FY23
Revenue$16.7M$14.1M$12.6M$11.9M
Gross profit$10.4M$8.9M$8.0M$7.2M
Operating income$3.2M$2.5M$2.1M$1.5M
EBITDA$4.3M$3.4M$2.9M$2.3M
EBIT$3.4M$2.5M$2.1M$1.6M
Interest expense$216.0K$20.0K$23.0K$27.0K
Pretax income$3.2M$2.5M$2.1M$1.6M
Tax$919.0K$639.0K$246.0K$166.0K
NPAT$2.2M$1.9M$1.8M$1.4M
Net interest income−$223.0K$27.0K$32.0K$51.0K
EPS basic$0.046 (source: Derived: trailing 12 months at year end)$0.039$0.038$0.029
EPS diluted$0.043 (source: Derived: trailing 12 months at year end)$0.038$0.038$0.029
Shares48.8M48.8M48.8M48.8M
  • Derived: trailing 12 months at year end